DETECTION OF HUMAN PAPILLOMAVIRUS BY SELF-SAMPLING: A NEW MODEL FOR CERVICAL CANCER SCREENING

Main Article Content

Raxmanova N.Q.,Aripov O.A

Abstract

Human papillomavirus (HPV) through self-sampling, presenting a promising model for cervical cancer screening. The method involves individuals collecting their own samples, potentially revolutionizing the screening process by increasing accessibility and convenience. The efficacy and reliability of this self-sampling method in identifying HPV infections are explored, along with its implications for early detection and prevention of cervical cancer. This innovative model offers a convenient and effective strategy for expanding screening efforts and reducing the burden of cervical cancer worldwide.

Article Details

How to Cite
Raxmanova N.Q.,Aripov O.A. (2024). DETECTION OF HUMAN PAPILLOMAVIRUS BY SELF-SAMPLING: A NEW MODEL FOR CERVICAL CANCER SCREENING. Uz-Conferences, 349–354. Retrieved from https://uz-conference.com/index.php/p/article/view/533
Section
Articles

References

«Cervical screening: programme overview». GOV.UK. Public Health England. 2. «Leopold Koss». New York Times. Legacy.com. September 15, 2012. Retrieved 14 October 2012. 3. Andrae B, Kemetli L, Sparén P, Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008; 100:605–606. 4. Arbyn, M. et al. Worldwide burden of cervical cancer in 2008. Ann. Oncol. 22, 2675–2686 (2011). 5. Baseman, J. G. & Koutsky, L. A. The epidemiology of human papillomavirus infections. J. Clin. Virol. 32 (Suppl. 1), S16– S24 (2005). 6. Chow, L. T., Broker, T. R., & Steinberg, B. M. The natural history of human papillomavirus infections of the mucosal epithelia. APMIS 118, 422–449 (2010). 7. Dhiraj B. Nikumbh, Roopali D. Limitations of cytological cervical cancer screening (Papanicolaou test) regarding technical and cultural aspect in rural IndiaAsian J Cancer. 2016 Apr-Jun; 5(2): 79. 8. Doorbar, J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. 110, 525–541 (2006). 9. Doorbar, J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. 110, 525–541 (2006).

Durst, M., Gissmann, L., Ikenberg, H. & zur Hausen, H. Apapillomavirus DNAfrom a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl Acad. Sci. USA 80, 3812–3815 (1983). 11.I Wikström, M Lindell, K Sanner, and E Wilander. Self-sampling and HPV testing or ordinary Pap smear in women not regularly attending screening: a randomised study Br J Cancer. 2011 Jul 26; 105(3): 337–339. 12. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. — IARC, 2006.